This post Buy Small-Cap Stocks to Avoid the “Rotating Blades of Death” appeared first on Daily Reckoning.
Fish yourself a Dow stock out of the earnings pond.
Go ahead—grab your rod and reel one in.
Now ask yourself this question: Will it blend?
The start of a new year causes many people to vow to change, make resolutions or try something new — after their hangover wears off anyway. For investors, it can be a good time to review their portfolios, investment goals and strategies: Is your investment plan working? Is your advisor earning his or her keep? Is your portfolio diversified and balanced?
By Chris Katje: Last week, shares of TearLab Corporation (TEAR) jumped 12.6%. The move came from increased volume and a buy recommendation from stock picker and CNBC host Jim Cramer. The company is still underfollowed and undervalued, but that is about to change.
Today’s big stock market winner is Sarepta Therapeutics (SRPT), a small biotech company developing Eteplirsen, a novel therapy for Duchenne Muscular Dystrophy. Shares are rocketing higher by a stunning 175% today, from $15 to $41 each, on news that a phase 2 study showed promising results compared with placebo.